Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4. (Q41473476)

1 October 2017

Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4. (English)

1 reference

1 October 2017

0 references

1 reference

Derocq JM

1

1 reference

1 October 2017

Segui M

2

1 reference

1 October 2017

Poinot-Chazel C

3

1 reference

1 October 2017

Minty A

4

1 reference

1 October 2017

Caput D

5

1 reference

1 October 2017

Ferrara P

6

1 reference

1 October 2017

Casellas P

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

1 October 2017

1 reference

1 October 2017

343

1 reference

1 October 2017

1

1 reference

1 October 2017

32-36

1 reference

Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Expression and function of interleukin-6 in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin 6: insights to its function in skin by overexpression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Effects of SV40 transformation on the cytoskeleton and behavioural properties of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin-6: molecular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

Clinical features, pathogenic mechanisms, and new developments in the treatment of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2980601-2

10.1016/0014-5793(94)80601-2

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference